Form 8-K - Current report:
SEC Accession No. 0001193125-20-196496
Filing Date
2020-07-22
Accepted
2020-07-21 18:08:03
Documents
15
Period of Report
2020-07-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d95290d8k.htm   iXBRL 8-K 29273
2 EX-99.1 d95290dex991.htm EX-99.1 14464
6 GRAPHIC g95290g0721065747566.jpg GRAPHIC 2307
7 GRAPHIC g95290g0721070046011.jpg GRAPHIC 2613
  Complete submission text file 0001193125-20-196496.txt   181283

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA biib-20200716.xsd EX-101.SCH 3076
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20200716_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20200716_pre.xml EX-101.PRE 10957
8 EXTRACTED XBRL INSTANCE DOCUMENT d95290d8k_htm.xml XML 3191
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 201039759
SIC: 2836 Biological Products, (No Diagnostic Substances)